Fig. 3From: Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysisForest plot displaying a random-effects meta-analysis of the effect of GM1 on the incidence of grade ≥ 2 chemotherapy-induced peripheral neuropathy using the common terminology criteria for adverse events (CTCAE)Back to article page